Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» This May Be Pfizer's Key to Long-Term Vaccine Dominance
This May Be Pfizer's Key to Long-Term Vaccine Dominance
This May Be Pfizer's Key to Long-Term Vaccine Dominance
Submitted by
admin
on July 6, 2022 - 10:36am
Source:
Motley Fool
News Tags:
Pfizer
vaccines
COVID-19
pan-coronavirus vaccine
Headline:
This May Be Pfizer's Key to Long-Term Vaccine Dominance
snippet:
Pfizer is already the leader in the coronavirus vaccine market.
The company predicts its vaccine will generate $32 billion in revenue this year.
A candidate in development may address one of today’s biggest challenges, and that could equal lasting dominance.
Do Not Allow Advertisers to Use My Personal information